Anaptysbio (ANAB) Revenue Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3,790.58% |
| 10 | Anaptysbio | 1.60 Bn | 1.31 Bn | - | -7.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.98% |
| Dec 31, 2025 | 200.00% |
| Sep 30, 2025 | 233.33% |
| Jun 30, 2025 | 102.93% |
| Mar 31, 2025 | 286.84% |
| Dec 31, 2024 | 177.62% |
| Sep 30, 2024 | 352.08% |
| Jun 30, 2024 | 217.08% |
| Mar 31, 2024 | 422.49% |
| Dec 31, 2023 | 80.10% |
| Sep 30, 2023 | 156.61% |
| Jun 30, 2023 | 184.54% |
| Mar 31, 2023 | 41.65% |
| Dec 31, 2022 | 394.56% |
| Sep 30, 2022 | -93.54% |
| Jun 30, 2022 | -93.92% |
| Mar 31, 2022 | -90.30% |
| Dec 31, 2021 | -98.32% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | 1,900.00% |
| Dec 31, 2017 | 200.00% |
| Jun 30, 2017 | -25.00% |